Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2790 Results
Invitation to Cover: Managing Cell and Human Identity

Invitation to Cover: Managing Cell and Human Identity

Genetic, stem cell, and reproductive technologies that have the capability to fundamentally change our cells is challenging what is means to be human.

Karen Kreeger

Two at Penn Honored by National Minority Quality Forum

Two at Penn Honored by National Minority Quality Forum

Two members of the University of Pennsylvania community have been named recipients of the National Minority Quality Forum’s 40 Under 40 Leaders in Minority Health Award, recognizing young minority thought leaders who are working to reduce health-c

Jacquie Posey , John Infanti

Penn Study: Clinical Trial Shows Benefit of Yoga for Side Effects of Prostate Cancer Treatment

Penn Study: Clinical Trial Shows Benefit of Yoga for Side Effects of Prostate Cancer Treatment

Men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn’t, according to a clinical trial led by the Perelman School of Medicine at the University of Pennsylvania.

John Infanti

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients with BRCA1 mutations are considered candidates for the treatment, but there is no method to measure the enzyme levels to help guide treatment choices.

John Infanti

Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research Grants

Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research Grants

Two doctors in the Perelman School of Medicine at the University of Pennsylvania have been awarded Immuno-Oncology Innovative Research Grants (IRG) by Stand Up to Cancer (SU2C). Michael Farwell, MD, an assistant professor of Radiology, and Gregory L. Beatty, MD, PhD, an assistant professor of Hematology Oncology, and are two of just 10 researchers to receive these grants.

John Infanti

Link between Common Prostate Cancer Treatment, Dementia Detailed in New Penn Study

Link between Common Prostate Cancer Treatment, Dementia Detailed in New Penn Study

A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

John Infanti